Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWIFT-C: Sofosbuvir Regimens for Acute HCV in HIV-Infected Individuals
NCT02128217Phase 1Completed
- Start
- May 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sofosbuvir and ledipasvir in hepatitis C virus infection (2 cohorts). Primary endpoints: Sustained Virologic Response 12 and Adverse Events Grade >= 2. Started May 2014; status: completed.
02
Drugs
sofosbuvirledipasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02128217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02128217.